Browsing Centre for Immunobiology by Author "Yan, M"
Now showing items 1-1 of 1
-
Brief Report: Long-Term (96-Week) Efficacy and Safety After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in HIV-Infected, Virologically Suppressed Adults.
Raffi, F; Orkin, C; Clarke, A; Slama, L; Gallant, J; Daar, E; Henry, K; Santana-Bagur, J; Stein, DK; Bellos, N (2017-06-01)In a double-blind, phase 3 trial, 663 HIV-infected, virologically suppressed adults were randomized to switch to tenofovir alafenamide (TAF; n = 333) vs. remain on tenofovir disoproxil fumarate (TDF; n = 330), each ...